Gansevoort RT, Arici M, Benzing T. Recommendations for the use of tolvaptan in autosomal dominant polycystic kidney disease: a position statement on behalf of the ERA-EDTA Working Groups on Inherited Kidney Disorders and European Renal Best Practice. KIDNEYS [Internet]. 2021 Sep. 9 [cited 2026 Jan. 11];(3.17):34-8. Available from: https://kidneysjournal.com/index.php/journal/article/view/129